Diabetes and COVID-19 testing, positivity, and mortality: A population-wide study in Northern Italy.

ABSTRACT:

Aims

To assess if patients with type 2 diabetes mellitus (DM2) are: a) at excess risk of undergoing testing, contracting, and dying from SARS-CoV-2 infection compared to the general population; b) whether cardiovascular diseases (CAVDs) contribute to COVID-19-related death; and c) what is the effect of DM2 duration and control on COVID-19-related death.

Methods

This population-based study involved all 449,440 adult residents of the Reggio Emilia province, Italy. DM2 patients were divided in groups by COVID testing, presence of CAVDs and COVID death. Several mediation analyses were performed.

Results

Patients with DM2 had an increased likelihood of being tested (Odds ratio, OR 1.27 95 %CI 1.23-1.30), testing positive (OR 1.21 95 %CI 1.16-1.26) and dying from COVID-19 (

SUBMITTER: Djuric O 

PROVIDER: S-EPMC9417741 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature